Defining Optimal Triage Strategies for hrHPV Screen–Positive Women—An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry

Autor: Grazyna A. Stanczuk, Timothy M. Palmer, Marc Arbyn, William Forson, Lynne Patterson, Janice Black, Gwen Baxter, Lynn Govan, Kate Cuschieri, Heather Currie, A. Wilson, James R. Lawrence

Publikováno v: Stanczuk, G A, Baxter, G J, Currie, H, Forson, W, Lawrence, J R, Cuschieri, K, Wilson, A, Patterson, L, Govan, L, Black, J, Palmer, T & Arbyn, M 2017, ' Defining optimal triage strategies for hrHPV screen positive women-an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry. ', Cancer Epidemiology, Biomarkers and Prevention, pp. cebp.0534.2017 . https://doi.org/10.1158/1055-9965.EPI-17-0534

Background: Several options for the triage of high-risk HPV screen–positive (hrHPV+) women were assessed. Methods: This study incorporated CIN2+ cases and controls, all of whom tested hrHPV+ and whose results of liquid-based cytology (LBC), HPV16/1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b980f8d0e71dc05e1770242a4b88687e
https://doi.org/10.1158/1055-9965.epi-17-0534